| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 4.790 | 60.126 | 64.607 | 67.685 | 81.778 | 102.321 |
| Total Income - EUR | - | - | - | - | 4.790 | 62.194 | 64.609 | 67.687 | 81.780 | 102.324 |
| Total Expenses - EUR | - | - | - | - | 1.013 | 24.649 | 17.315 | 24.104 | 22.262 | 23.782 |
| Gross Profit/Loss - EUR | - | - | - | - | 3.777 | 37.545 | 47.294 | 43.582 | 59.518 | 78.542 |
| Net Profit/Loss - EUR | - | - | - | - | 3.729 | 36.973 | 46.660 | 42.953 | 58.717 | 75.687 |
| Employees | - | - | - | - | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Rodimorar-Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 908 | 798 | 683 | 568 |
| Current Assets | - | - | - | - | 4.832 | 40.636 | 47.030 | 44.094 | 60.915 | 80.152 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 4.790 | 4.994 | 36.475 | 35.134 | 55.176 | 27.769 |
| Cash | - | - | - | - | 42 | 35.642 | 10.555 | 8.961 | 5.739 | 52.383 |
| Shareholders Funds | - | - | - | - | 3.771 | 37.023 | 46.709 | 43.002 | 58.765 | 75.735 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 1.061 | 3.613 | 1.229 | 1.890 | 2.833 | 4.984 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Rodimorar-Med S.r.l.